Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06957678

AI-Based Prediction of Lymph Node Metastasis in Gastric Cancer Using Preoperative Multimodal Data

Artificial Intelligence-Based Prediction of Lymph Node Metastasis and Nodal Station Involvement in Gastric Cancer Using Preoperative Multimodal Imaging and Pathology Data

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
1,200 (estimated)
Sponsor
Qun Zhao · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers

Summary

This study aims to develop and validate an artificial intelligence (AI) system that can predict whether lymph node metastasis has occurred in patients with gastric cancer before surgery. Using preoperative imaging and pathology data, the AI models will not only predict if metastasis is present but also identify which specific lymph node stations or individual lymph nodes are involved. All lymph nodes will be carefully removed during surgery and examined one by one with detailed pathological methods to ensure accurate diagnosis. The goal is to improve the accuracy of lymph node assessment and assist doctors in making better treatment decisions.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTArtificial Intelligence-Based Predictive Model for Lymph Node MetastasisThe intervention is an artificial intelligence-based predictive model developed using preoperative multimodal data, including contrast-enhanced CT images, preoperative histopathological findings, and clinical features. The model is designed to predict (1) the presence or absence of lymph node metastasis, (2) the specific lymph node stations involved, and (3) the individual lymph nodes involved. Each lymph node's metastatic status is confirmed by serial pathological sectioning of surgically retrieved nodes, ensuring a highly accurate reference standard for model training and validation. This distinguishes the intervention from traditional imaging-based assessments and from other AI models that do not use individually validated lymph node pathology.

Timeline

Start date
2025-01-01
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2025-05-04
Last updated
2025-05-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06957678. Inclusion in this directory is not an endorsement.